Detalhe da pesquisa
1.
Safety and effectiveness of three novel all-oral shortened regimens for rifampicin- or multidrug-resistant tuberculosis in Kazakhstan.
Clin Infect Dis
; 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38833593
2.
Association of indicators of extensive disease and rifampin-resistant tuberculosis treatment outcomes: an individual participant data meta-analysis.
Thorax
; 79(2): 169-178, 2024 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38135489
3.
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort.
Eur Respir J
; 62(5)2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37827576
4.
All-oral longer regimens are effective for the management of multidrug-resistant tuberculosis in high-burden settings.
Eur Respir J
; 59(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34140298
5.
Improving healthcare for patients with HIV, tuberculosis and hepatitis C in eastern Europe: a review of current challenges and important next steps.
HIV Med
; 23(1): 48-59, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34468073
6.
Optima TB: A tool to help optimally allocate tuberculosis spending.
PLoS Comput Biol
; 17(9): e1009255, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34570767
7.
Patient and health-care provider experience of a person-centred, multidisciplinary, psychosocial support and harm reduction programme for patients with harmful use of alcohol and drug-resistant tuberculosis in Minsk, Belarus.
BMC Health Serv Res
; 22(1): 1217, 2022 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180873
8.
Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe: associated factors and effect on mortality-a multicentre prospective cohort study.
BMC Infect Dis
; 21(1): 1038, 2021 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34615474
9.
Effectiveness and cardiovascular safety of delamanid-containing regimens in adults with multidrug-resistant or extensively drug-resistant tuberculosis: A nationwide cohort study from Belarus, 2016-18.
Monaldi Arch Chest Dis
; 91(1)2021 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33470081
10.
Effectiveness and safety of delamanid- or bedaquiline-containing regimens among children and adolescents with multidrug resistant or extensively drug resistant tuberculosis: A nationwide study from Belarus, 2015-19.
Monaldi Arch Chest Dis
; 91(1)2021 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33470080
11.
Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data.
PLoS Med
; 17(1): e1003008, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31961877
12.
Factors contributing to drug-resistant tuberculosis treatment outcome in five countries in the Eastern Europe and Central Asia region.
Monaldi Arch Chest Dis
; 90(1)2020 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32231347
13.
Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis.
Emerg Infect Dis
; 25(3): 441-450, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30789141
14.
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.
Eur Respir J
; 54(6)2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31601711
15.
Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries.
Am J Respir Crit Care Med
; 198(3): 379-386, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29509468
16.
Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings.
Emerg Infect Dis
; 24(8)2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30016256
17.
Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
PLoS Med
; 15(7): e1002591, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29995958
18.
Population Pharmacokinetic Model and Limited Sampling Strategies for Personalized Dosing of Levofloxacin in Tuberculosis Patients.
Antimicrob Agents Chemother
; 62(12)2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30373800
19.
New and Repurposed Drugs for Pediatric Multidrug-Resistant Tuberculosis. Practice-based Recommendations.
Am J Respir Crit Care Med
; 195(10): 1300-1310, 2017 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27854508
20.
Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis.
Emerg Infect Dis
; 23(10)2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28758889